ATHA
Price
$3.86
Change
+$0.05 (+1.31%)
Updated
Sep 26 closing price
Capitalization
15.22M
38 days until earnings call
SQZB
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Sep 26 closing price
Capitalization
825.75K
38 days until earnings call
Interact to see
Advertisement

ATHA vs SQZB

Header iconATHA vs SQZB Comparison
Open Charts ATHA vs SQZBBanner chart's image
Athira Pharma
Price$3.86
Change+$0.05 (+1.31%)
Volume$16.48K
Capitalization15.22M
SQZ Biotechnologies
Price$0.03
Change-$0.00 (-0.00%)
Volume$316
Capitalization825.75K
ATHA vs SQZB Comparison Chart in %
Loading...
ATHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SQZB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATHA vs. SQZB commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATHA is a StrongBuy and SQZB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (ATHA: $3.86 vs. SQZB: $0.03)
Brand notoriety: ATHA and SQZB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATHA: 65% vs. SQZB: 25%
Market capitalization -- ATHA: $15.22M vs. SQZB: $825.75K
ATHA [@Biotechnology] is valued at $15.22M. SQZB’s [@Biotechnology] market capitalization is $825.75K. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATHA’s FA Score shows that 1 FA rating(s) are green whileSQZB’s FA Score has 1 green FA rating(s).

  • ATHA’s FA Score: 1 green, 4 red.
  • SQZB’s FA Score: 1 green, 4 red.
According to our system of comparison, ATHA is a better buy in the long-term than SQZB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATHA’s TA Score shows that 5 TA indicator(s) are bullish while SQZB’s TA Score has 3 bullish TA indicator(s).

  • ATHA’s TA Score: 5 bullish, 6 bearish.
  • SQZB’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, SQZB is a better buy in the short-term than ATHA.

Price Growth

ATHA (@Biotechnology) experienced а -0.26% price change this week, while SQZB (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

ATHA is expected to report earnings on Nov 06, 2025.

SQZB is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATHA($15.2M) has a higher market cap than SQZB($826K). SQZB YTD gains are higher at: -6.667 vs. ATHA (-34.208).
ATHASQZBATHA / SQZB
Capitalization15.2M826K1,840%
EBITDAN/AN/A-
Gain YTD-34.208-6.667513%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total Debt1.02MN/A-
TECHNICAL ANALYSIS
Technical Analysis
ATHASQZB
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
67%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
77%
Momentum
ODDS (%)
Bullish Trend 3 days ago
83%
N/A
MACD
ODDS (%)
Bullish Trend 3 days ago
85%
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
69%
Advances
ODDS (%)
Bullish Trend 10 days ago
82%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
85%
Aroon
ODDS (%)
Bearish Trend 3 days ago
84%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ATHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SQZB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RSSS3.850.04
+1.05%
Research Solutions
IT264.091.69
+0.64%
Gartner
CPS36.890.17
+0.46%
Cooper-Standard Automotive
AWX2.61-0.02
-0.61%
Avalon Holdings Corp
VNET10.80-0.33
-2.96%
VNET Group

SQZB and

Correlation & Price change

A.I.dvisor tells us that SQZB and ATHA have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SQZB and ATHA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SQZB
1D Price
Change %
SQZB100%
N/A
ATHA - SQZB
26%
Poorly correlated
+1.31%
OLMA - SQZB
13%
Poorly correlated
+16.12%
BRTX - SQZB
9%
Poorly correlated
-1.38%
ENTBF - SQZB
5%
Poorly correlated
-9.76%
ALGS - SQZB
2%
Poorly correlated
+4.59%
More